Cargando…

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?

Detalles Bibliográficos
Autores principales:	Scafuri, Luca, Sciarra, Antonella, Crocetto, Felice, Ferro, Matteo, Buonerba, Carlo, Ugliano, Francesco, Guerra, Germano, Sanseverino, Roberto, Lorenzo, Giuseppe Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558855/ https://www.ncbi.nlm.nih.gov/pubmed/34737893 http://dx.doi.org/10.2144/fsoa-2021-0092

Ejemplares similares

COVID-19 and prostate cancer: a complex scenario with multiple facets
por: Crocetto, Felice, et al.
Publicado: (2021)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Crocetto, Felice, et al.
Publicado: (2021)

The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2015)

Urologic malignancies: advances in the analysis and interpretation of clinical findings
por: Crocetto, Felice, et al.
Publicado: (2021)

Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Buonerba, Carlo, et al.
Publicado: (2020)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Editorial: Optimal perioperative management of urothelial carcinoma
por: Holzman, Ariane, et al.
Publicado: (2023)

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
por: Barone, Biagio, et al.
Publicado: (2022)

Does Exist a Differential Impact of Degarelix Versus LHRH Agonists on Cardiovascular Safety? Evidences From Randomized and Real-World Studies
por: Sciarra, Alessandro, et al.
Publicado: (2021)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
por: Franzese, Elisena, et al.
Publicado: (2021)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

Mediterranean Diet as a Supportive Intervention in Cancer Patients: Current Evidence and Future Directions
por: Rubino, Roberta, et al.
Publicado: (2022)

Nature’s hidden gem: quercitrin’s promising role in preventing prostate and bladder cancer
por: Mirto, Benito Fabio, et al.
Publicado: (2023)

Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
por: Ferro, Matteo, et al.
Publicado: (2021)

Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
por: Giannopoulou, Aikaterini F., et al.
Publicado: (2019)

Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis
por: Goldberg, Hanan, et al.
Publicado: (2018)

Immune checkpoint inhibitors in penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2021)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma
por: Kolawa, Adam, et al.
Publicado: (2023)

Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic
por: Terracciano, Daniela, et al.
Publicado: (2020)

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology
por: Napodano, Giorgio, et al.
Publicado: (2021)

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
por: Klain, Michele, et al.
Publicado: (2021)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Perioperative Care for Organ Transplant Recipient: Time for Paradigm Shift
por: Vitin, Alexander A.
Publicado: (2019)

Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors
por: Iacovino, Maria Lucia, et al.
Publicado: (2022)

Zoanthropy in confinement
por: Guerra, M.F. Tascon, et al.
Publicado: (2021)

Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
por: Crocetto, Felice, et al.
Publicado: (2020)

Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis
por: Yang, Xiao, et al.
Publicado: (2016)

POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma – A standard of care?
por: Ranjan, Satish Kumar
Publicado: (2020)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

A Perioperative Paradigm of Cranioplasty With Polyetheretherketone: Comprehensive Management for Preventing Postoperative Complications
por: He, Zhenghui, et al.
Publicado: (2022)

The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma
por: Erlmeier, F., et al.
Publicado: (2016)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pda8ogbmnsha3pvo2p1tqtk6r8